NYSE: LLY
Eli Lilly and Company (LLY) Stock Analysis
Eli Lilly develops pharmaceutical products for endocrinology, oncology, and neuroscience. Aphelion AI tracks LLY stock.
Company Overview
| Symbol | LLY |
|---|---|
| Company | Eli Lilly and Company |
| Exchange | NYSE |
| Sector | Healthcare |
| Market Cap | $750B |
| CEO | David Ricks |
| Founded | 1876 |
| Headquarters | Indianapolis, IN |
Powered by GPT-4. Technical analysis, fundamentals, and AI insights in one report.
Frequently Asked Questions about LLY
What does Eli Lilly and Company (LLY) do?
Eli Lilly develops pharmaceutical products for endocrinology, oncology, and neuroscience. Aphelion AI tracks LLY stock.
Where is LLY traded?
Eli Lilly and Company (LLY) is traded on the NYSE stock exchange. You can analyze LLY using Aphelion AI's real-time analysis tools.
How can I analyze LLY stock?
Aphelion AI provides AI-powered analysis for LLY including technical indicators, fundamental metrics, earnings data, and sentiment analysis. Simply search for LLY in our analysis tool for a comprehensive report.
What sector is LLY in?
Eli Lilly and Company operates in the Healthcare sector. You can explore other Healthcare stocks on Aphelion AI's sector page.